Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Inflammation 1Frailty 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × microcrystalline cellulose × 1 year × Clear all
NCT07149649 2026-03-27

Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)

Swiss Cancer Institute

Phase 2/3 Not yet recruiting
230 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06068543 2026-03-06

ReFOCUS2

University of Rochester

Phase 2 Recruiting
118 enrolled

Frailty, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡